Base Resources Limited (ASX:BSE)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 12, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	311	315	198	330	353	211
Market Cap Growth	58.75%	58.75%	-39.80%	-6.73%	67.56%	-24.68%
Enterprise Value	179	199	110	280	256	164
Last Close Price	0.19	0.20	0.10	0.14	0.12	0.06
PE Ratio	-	-125.68	-16.63	1.45	9.95	1.21
PS Ratio	1.47	1.56	0.49	0.81	1.34	0.70
PB Ratio	0.77	0.82	0.46	0.68	0.83	0.40
P/FCF Ratio	-	9.48	1.67	3.83	6.63	2.02
P/OCF Ratio	-	4.62	1.12	2.90	4.11	1.38
EV/Sales Ratio	0.88	0.98	0.27	0.69	0.97	0.54
EV/EBITDA Ratio	3.49	3.94	0.46	1.20	2.00	1.04
EV/EBIT Ratio	5.41	6.04	0.60	1.59	5.18	2.16
EV/FCF Ratio	5.37	6.00	0.93	3.25	4.81	1.57
Debt / Equity Ratio	-	-	-	-	-	0.20
Debt / EBITDA Ratio	-	-	-	-	-	0.68
Debt / FCF Ratio	-	-	-	-	-	1.03
Asset Turnover	0.37	0.37	0.70	0.69	0.42	0.42
Inventory Turnover	3.64	3.64	6.34	7.87	7.36	7.13
Quick Ratio	1.92	1.92	4.00	3.81	1.89	2.37
Current Ratio	2.35	2.35	4.86	4.55	2.29	2.67
Return on Equity (ROE)	-0.60%	-0.60%	-1.56%	24.71%	3.22%	11.59%
Return on Assets (ROA)	3.79%	3.79%	19.88%	18.65%	4.87%	6.64%
Return on Capital (ROIC)	5.04%	5.04%	24.64%	23.13%	6.12%	8.41%
Earnings Yield	-	-0.78%	-3.67%	35.56%	4.14%	27.19%
FCF Yield	-	10.55%	59.73%	26.09%	15.07%	49.41%
Dividend Yield	-	-	57.61%	41.83%	57.31%	59.79%
Payout Ratio	-	-	-	75.44%	513.46%	-
Buyback Yield / Dilution	-0.49%	-0.49%	2.26%	0.63%	-0.83%	-1.20%
Total Shareholder Return	-0.49%	-0.49%	59.87%	42.47%	56.48%	58.59%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.